News About: Pharm. Industry
Lipitor market warming up
The domestic market of Pfizer’s Lipitor is gaining momentum with the leading two drug markers, such as Dong-A Pharm and Yuhan Corporation, who see opportunities in the field where Pfizer has been dominating.
The tw...
Chong Kun Dang to launch anti-clotting agentChong Kun Dang Pharmaceutical is considering launching its chemical modified Prigrel tablet (clopidogrel reginate) in the domestic thrombolytic market dominated by Sanofi-Aventi...
|
Choong-wae Holdings buys 18.5% stake in Three Seven Inc
Choong-Wae Holdings announced on May 30 that it acquired an 18.5 percent stake in Three Seven Inc., which owns Creagene, a local bio-venture company.
“We decided to buy the stake to solidify our current partnership...
Prices of chemically modified Plavix to fall
There is mounting discomfort among six domestic producers of chemically modified Plavix, anticlotting medicine, that the prices of their products will be decreased by lower than 68 percent over the original drug.
T...
Wholesaler showing skepticism over another price increase of Mentholatum lotion
The expected 10-percent price increase of Mentholatum lotion in July irritates drug wholesalers.
Many wholesalers said that if the price of Metholatum lotion rises from 2,900 won to 3,300 won, they will have to se...
94 pharmaceutical manufacturers uneasy about court ruling
The Seoul Administrative Court rejected an administrative suit against the Minister of Health, Welfare and Family Affairs, which was filed by 94 Korean pharmaceutical firms on June of last year, seeking a cancellation...
Soaring oil prices and weaker won to raise renowned OTC items from June
Influenced by rising international prices of crude oil and raw materials costs, the prices of such renowned OTC brand items as vitamin C preparations and hair dyes will rise 10-30 percent from next month.
Leading O...
Shares of Yuyu, Yungjin rallied
Shares of two pharmaceutical companies – Yuyu and Yungjin - reached a record high during trading on May 27, driven by bright prospects of new drug development and pharmaceutical bulk export.
Yuyu shares ended up 1...
KDI’s statement losing rationale
The recent Korea Development Institute’s statement that Korean generic medicines are more expensive than foreign counterparts came under fire from the domestic pharmaceutical industry.
The industry is casting a dou...
Feud between Dong-A, wholesalers deepens over margin
Conflicts are intensifying between Dong-A Pharm and its associate wholesalers, over the falling wholesaler margin.
The Korean Association of Pharmaceutical Wholesaler has urged its member wholesalers to reject any ...
